Hung Chang
Impact in
-
- Lymphoma Diagnosis and Treatment
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
Papers in
- Hematology 27
- Platelet Disorders and Treatments 12
- Acute Myeloid Leukemia Research 10
-
- Lymphoma Diagnosis and Treatment 27
- Co-authors
- Yu‐Shin Hung (41 shared papers)Tzung‐Chih Tang (28 shared papers)Ming‐Chung Kuo (43 shared papers)Po‐Nan Wang (33 shared papers)Lee‐Yung Shih (35 shared papers)Jin‐Hou Wu (37 shared papers)Tung‐Liang Lin (18 shared papers)Po Dunn (17 shared papers)
- Journals
- Acta Haematologica (10 papers)European Journal Of Haematology (5 papers)Biomedical Journal (3 papers)Clinical and Experimental Medicine (3 papers)Blood (3 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Hung Chang
95 papers receiving 1.8k citations
Hung Chang's Hit Papers
Peers
Comparison fields: 5 of 83
- Pathology and Forensic Medicine 700
- Hematology 208
- Internal Medicine 41
- Physiology 39
- Oncology 163
Countries citing papers authored by Hung Chang
This map shows the geographic impact of Hung Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung Chang more than expected).
Fields of papers citing papers by Hung Chang
This network shows the impact of papers produced by Hung Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung Chang. The network helps show where Hung Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hung Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial Hit paper breakdown → | 2018 | 561 |
| 2 | 2018 | 103 | |
| 3 | 2011 | 79 | |
| 4 | 2017 | 66 | |
| 5 | 2010 | 46 | |
| 6 | 2015 | 40 | |
| 7 | 2009 | 38 | |
| 8 | 2012 | 38 | |
| 9 | 2006 | 35 | |
| 10 | 2012 | 34 | |
| 11 | 2015 | 33 | |
| 12 | 2013 | 31 | |
| 13 | 2015 | 30 | |
| 14 | 2013 | 25 | |
| 15 | 2014 | 24 | |
| 16 | 2018 | 24 | |
| 17 | 2018 | 22 | |
| 18 | 2018 | 20 | |
| 19 | 2018 | 20 | |
| 20 | 2017 | 19 |
About Hung Chang
Hung Chang is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Internal Medicine and Physiology, having authored 103 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (27 papers), Platelet Disorders and Treatments (12 papers), Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Palliative Care and End-of-Life Issues (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Adenosine and Purinergic Signaling (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (700 citations), Hematology (208 citations), Internal Medicine (41 citations), Physiology (39 citations) and Oncology (163 citations). Hung Chang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Yu‐Shin Hung, Tzung‐Chih Tang, Ming‐Chung Kuo, Po‐Nan Wang, Lee‐Yung Shih, Jin‐Hou Wu, Tung‐Liang Lin, Po Dunn, Wen‐Yu Chuang and Wen‐Chi Chou. Their work appears in journals such as Acta Haematologica, European Journal Of Haematology, Biomedical Journal, Clinical and Experimental Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.